Regeneron Pharmaceuticals (REGN)
(Delayed Data from NSDQ)
$1,184.69 USD
+5.76 (0.49%)
Updated Aug 30, 2024 04:00 PM ET
After-Market: $1,176.44 -8.25 (-0.70%) 7:58 PM ET
3-Hold of 5 3
D Value F Growth B Momentum D VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
11/07/2024
Time: -- |
9/2024 | $11.72 | -0.50% |
Earnings Summary
For their last quarter, Regeneron Pharmaceuticals (REGN) reported earnings of $11.56 per share, beating the Zacks Consensus Estimate of $10.57 per share. This reflects a positive earnings surprise of 9.37%. Look out for REGN's next earnings release expected on November 07, 2024. For the next earning release, we expect the company to report earnings of $11.72 per share, reflecting a year-over-year increase of 1.12%.
Earnings History
Price & Consensus
Zacks News for REGN
Biotech Stock Roundup: REGN's Drug Approval, LXRX, RYTM Stocks Gain on Update & More
REGN: What are Zacks experts saying now?
Zacks Private Portfolio Services